Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women

NCT04405323 PHASE1 COMPLETED

A study to learn how a drug (itraconazole) that is known to inhibit a certain enzym in the liver, impacts the body's ability to breakdown Lu AG06466 into breakdown products in healthy men and women. The main breakdown product is Lu AG06988.

Details

Lead sponsor	H. Lundbeck A/S
Phase	PHASE1
Status	COMPLETED
Enrolment	16
Start date	Wed May 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy

Interventions

• Lu AG06466
• Itraconazole

Countries

United States